Quantcast

Latest Clinical trial Stories

2014-07-25 12:25:15

COSTA MESA, Calif., July 25, 2014 /PRNewswire-iReach/ -- Full Service CRO WCCT Global welcomes Peter Nieto as the new Vice President of Business Development. Peter has been in the pharmaceutical industry for over 30 years in a number of different business development positions with some of the largest CROs in the industry. These positions were primarily related to business development/sales management and marketing. The experience he has obtained over the past 30 years makes him a...

2014-07-25 08:24:56

LUGANO, Switzerland, July 25, 2014 /PRNewswire/ -- The European Society for Medical Oncology (ESMO) has expressed concern that the proposed EU General Data Protection Regulation could make cancer research impossible and add a significant burden to cancer patients and doctors. (Logo: http://photos.prnewswire.com/prnh/20131128/654773 ) The proposed wording -'explicit and specific patient consent' - implies that researchers would have to approach patients and ask...

2014-07-24 23:13:47

DZS Clinical Services announced today that SBI Pharmaceuticals, the leading expert in research, development, and manufacturing of 5-ALA, has entered into a preferred provider agreement with DZS to manage several clinical programs related to the development of 5-ALA. Bound Brook, NJ (PRWEB) July 24, 2014 As part of the long-term strategic approach, DZS expects to manage numerous projects in the MENA region during 2014 with potential global expansion. "We are delighted to have a...

2014-07-24 08:33:56

ThermoDox® Continues to Demonstrate Impressive Local Response Rate in Refractory Patients LAWRENCEVILLE, N.J., July 24, 2014 /PRNewswire/ -- Celsion Corporation (NASDAQ: CLSN) announced today positive interim data from its ongoing open-label Phase 2 DIGNITY Trial of ThermoDox® in Recurrent Chest Wall Breast Cancer (RCWBC). The trial is designed to enroll 20 patients at several U.S. clinical sites and is evaluating ThermoDox in combination with mild hyperthermia. Of the 13 patients...

2014-07-24 08:33:44

Based on encouraging progression-free survival data, Lpath extends the study to a second cohort and considers additional proof-of-concept studies SAN DIEGO, July 24, 2014 /PRNewswire/ -- Lpath, Inc. (NASDAQ: LPTN), the industry leader in bioactive lipid-targeted therapeutics, reported interim results in a Phase 2a single-arm, open-label trial where ASONEP(TM) is being investigated as a treatment for metastatic renal cell carcinoma (RCC) in patients that have failed at least one...

2014-07-24 08:31:56

The Shared Investigator Platform, Built as an Industry Utility, Will Help Accelerate the Development of New Medicines TEANECK, N.J., July 24, 2014 /PRNewswire/ -- Cognizant (NASDAQ: CTSH) today announced that it has been selected by TransCelerate BioPharma Inc., a non-profit organization with membership representation from 19 major pharmaceutical companies, to develop a first-of-its-kind, subscription-based platform that will transform the way clinical sites collaborate with...

2014-07-23 16:26:42

LONDON, July 23, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Partial Seizure Global Clinical Trials Review, H2, 2014https://www.reportbuyer.com/product/2243634/Partial-Seizure-Global-Clinical-Trials-Review-H2-2014.htmlPartial Seizure Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, "Partial Seizure Global Clinical Trials Review, H2, 2014" provides data on the Partial Seizure clinical trial scenario. This report provides...

2014-07-23 16:26:38

LONDON, July 23, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Neonatal Seizures Global Clinical Trials Review, H2, 2014https://www.reportbuyer.com/product/2243633/Neonatal-Seizures-Global-Clinical-Trials-Review-H2-2014.htmlNeonatal Seizures Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, "Neonatal Seizures Global Clinical Trials Review, H2, 2014" provides data on the Neonatal Seizures clinical trial scenario. This report...

2014-07-23 16:26:32

LONDON, July 23, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Intracerebral Hemorrhage Global Clinical Trials Review, H2, 2014https://www.reportbuyer.com/product/2243630/Intracerebral-Hemorrhage-Global-Clinical-Trials-Review-H2-2014.htmlIntracerebral Hemorrhage Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, "Intracerebral Hemorrhage Global Clinical Trials Review, H2, 2014" provides data on the Intracerebral Hemorrhage...

2014-07-23 12:32:49

LONDON, July 23, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Hypoxic-Ischemic Encephalopathy Global Clinical Trials Review, H2, 2014https://www.reportbuyer.com/product/2243628/Hypoxic-Ischemic-Encephalopathy-Global-Clinical-Trials-Review-H2-2014.htmlHypoxic-Ischemic Encephalopathy Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, "Hypoxic-Ischemic Encephalopathy Global Clinical Trials Review, H2, 2014" provides data on...


Word of the Day
cruet
  • A vial or small glass bottle, especially one for holding vinegar, oil, etc.; a caster for liquids.
This word is Middle English in origin, and ultimately comes from the Old French, diminutive of 'crue,' flask.
Related